Antioxidant defence-related genetic variants are not associated with higher risk of secondary thyroid cancer after treatment of malignancy in childhood or adolescence
Authors
Ana Lina Vodusek
Department of Radiation Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Katja Goricar
Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Barbara Gazic
Department of Pathology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Vita Dolzan
Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Janez Jazbec
Department of Hematology and Oncology, University Children’s Hospital, Ljubljana, Slovenia
Language: English
Page range: 80 - 86
Submitted on: Feb 2, 2015
Accepted on: Feb 23, 2015
Published on: Feb 16, 2016
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2016 Ana Lina Vodusek, Katja Goricar, Barbara Gazic, Vita Dolzan, Janez Jazbec, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.